GNH USA

Europe — EMA

Octanine (Human Coagulation Factor Ix)

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as a for intravenous use.

Request sourcing

1
Pack/s

What is Human Coagulation Factor Ix?

Human Coagulation Factor IX, the active ingredient in Octanine, is a coagulation factor replacement therapy presented as a for intravenous use. It treats hemophilia B and related clotting disorders in patients requiring factor IX supplementation. GNH USA supplies Octanine as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Octanine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

What is Human Coagulation Factor Ix used for?

Octanine is a coagulation replacement therapy that addresses the intrinsic pathway of blood clot formation in hemophilia B patients and related conditions: - Hemophilia B: Provides temporary correction of factor IX deficiency to prevent bleeding episodes and support surgical procedures. - Acquired of the     ....

What are the side effects of Human Coagulation Factor Ix?

Common  

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Human Coagulation Factor Ix
Route
Intravenous Use
Manufacturer
Octapharma Ab
Origin
EU

Related products